Introduction {#s1}
============

*Hypericum perforatum* L. (Hypericaceae), or St. John\'s Wort, is a well-known medicinal herb regularly associated with the treatment of anxiety, historically determined by the ancient Greek physicians Pliny and Hippocrates (Blumenthal, [@B6]). The plant grows up to 1 m in height and features yellow flowers, rounded leaves, and oblong petals populated with a number of brown-black glandular dots, giving the plant its eponymous "perforated" appearance (WHO, [@B58]), Figure [1](#F1){ref-type="fig"}. It is native to Europe and Asia, while also having spread as an invasive species in North America and Oceania. Often used to treat depression and other mood disorders (Ng et al., [@B35]), dietary supplements featuring St. John\'s Wort reached an annual sale of \$6 million in the United States in 2015 (Smith et al., [@B53]). *H. perforatum* is well-characterized chemically: many secondary metabolites have been identified, including naphthodianthrones (hypericin), phloroglucinols (hyperforin), flavonoid glycosides (hyperoside), biflavones, and anthocyanidins (Porzel et al., [@B38]). Currently, many compounds are now understood in mechanism and function; for example, antidepressant activity has been attributed to hyperforin, which acts as a reuptake inhibitor for neurotransmitters such as dopamine, norepinepherine, serotonin, and glutamate (Chatterjee et al., [@B10]) and is now used in the standardization of many *Hypericum*-based products sold on the commercial market (USP, [@B56]).

![Traditional production of *H. perforatum* oil macerates for topical applications. **(A)** Plants are collected from the wild. **(B)** The flowering aerial parts are harvested. **(C)** The flowers are covered with oil (typically olive oil or sunflower oil) and exposed to the sun for 40 days. **(D)** The oil is ready for use once it has passed the sun exposure period and has taken on a blood red color.](fmicb-08-01639-g0001){#F1}

Additionally, an oil macerate of *H. perforatum* flowers (Oleum Hyperici) is widely used as a traditional remedy across Bosnia and Herzegovina, Turkey, and Serbia for skin ulcers and burns (Kültür, [@B24]; Redžić, [@B43]; Šarić-Kundalić et al., [@B45]; Savikin et al., [@B47]), as well as in Kosovo (Mustafa et al., [@B32],[@B33], [@B34]). The documentation of continued usages of the oil across the Balkan Peninsula stands in contrast to its less common use in the West. Historic literature indicates a past appreciation for the oil; *The Eclectic Dispensatory of the United States of America* quoted it as being "a fine red balsamic ointment for wounds, ulcers, swellings, tumors, etc." in 1852 (King, [@B22]), and *Potter\'s Cyclopaedia of Botanical Drugs and Preparations* described it as "a healing application to wounds, sores, ulcers, and swellings" to Londoners in 1907 (Wren, [@B60]). Recent research showed that polysaccharides from *H. perforatum* have antimicrobial activity against *Escherichia coli, Shigella dysenteriae, Salmonella typhi, Bacillus cereus*, and *Staphylococcus aureus* when tested by a disk diffusion assay (Heydarian et al., [@B20]). Another study demonstrated *H. perforatum* extracts and partitions had antibacterial activity against several oral bacteria including *Streptococcus mutans, S. sobrinus, Lactobacillus plantarum*, and *Enterococcus faecalis* (Suntar et al., [@B55]).

Oleum Hyperici is prepared in the Balkan region by covering the flowering aerial parts of the plant in olive or sunflower oil in a transparent container (glass or plastic) and exposing to sunlight for at least 40 days until it turns an intense red color (Mattalia et al., [@B30]), Figure [1](#F1){ref-type="fig"}. Recent research has shown that Oleum Hyperici reduces both external wound size and healing time as an antibacterial (Suntar et al., [@B54]). The phloroglucinol hyperforin and naphthodianthrone hypericin (Figure [2](#F2){ref-type="fig"}) are reported to be responsible for its antibacterial activity (Saddiqe et al., [@B44]), effective as antibacterial compounds against various Gram-positive bacteria (Schempp et al., [@B48]), including *Bacillus subtilis, E. faecalis, Staphylococcus epidermidis*, and *Micrococcus luteus* (Marcetic et al., [@B27]), while ineffective against Gram-negative bacteria (Gibbons et al., [@B18]). Many compounds other than the naphthodianthrone and phloroglucinol derivatives have been identified in *H. perforatum* flowers; including the flavonol hyperoside, biflavonols such as amentoflavone and biapigenin, low levels of xanthone derivatives, common phenolic acids such as caddeic acid, chlorogenic acid, and ferulic acid, tannins and catechin derivatives are also present at significant concentrations (Dostalek and Stark, [@B14]; Matei et al., [@B29]).

![Structures of two bioactive compounds, hyperforin **(14)** and hypericin **(18)**, examined in our chemical analysis of the *H. perforatum* extracts and traditional formulas.](fmicb-08-01639-g0002){#F2}

Nevertheless, phloroglucinols are quite unstable with light and heat (Orth et al., [@B37]; Ang et al., [@B1]), and thus should not be present in an aged oil macerate of *H. perforatum*. Hyperforin, specifically, is susceptible to oxidation into furohyperforin, which is completely ineffective when treating Gram-positive and Gram-negative bacteria (Miraldi et al., [@B31]). Additionally, hypericin can cause phototoxic skin reactions if ingested or absorbed into the skin (Kamuhabwa et al., [@B21]), known as "hypericism"---a common pharmaceutical warning for fair-skinned individuals taking *Hypericum* supplements or evidenced by livestock that develop extreme photosensitivity after grazing on *H. perforatum* flowers (Genter, [@B17])---as UV-activated hypericin has been demonstrated to kill human keratinocytes and melanocytes by means of necrosis and apoptosis (Davids et al., [@B13]). While hypericin is often cited as the main photosensitizing agent, pseudohypericin and hyperforin may also contribute to the phototoxicity of *H. perforatum* preparations (Onoue et al., [@B36]). Although hypericin in a *H. perforatum* extract or in combination with other compounds found in *H. perforatum*, such as chlorgenic acid, can exhibit a lower phototoxicity than the hypericin alone (Schmitt et al., [@B50]).

Therefore, the established chemistry presents an interesting paradox to this traditional preparation of *H. perforatum*. The hyperforin thought to be responsible for much of the antibacterial bioactivity should degrade in the sunlight as the remedy is prepared, unless the oil increases the stability of certain terpenoids as it is known to do (Boskou, [@B8]) that, in turn, act as sacrificial antioxidants for hyperforin. Alternately, if hypericin is present in established bioactive levels and contributes to the oil\'s red colorization, then the traditionally prepared oil macerate should cause photosensitivity, yet none is reported. Here, we approach two central questions: (1) Do traditionally formulated Oleum Hyperici from the Balkans contain the phototoxic compound, hypericin; and (2) Does the anti-staphylococcal activity of various *H. perforatum* formulations differ? Based on a lack of skin sensitization reports following use of the oil (data from previous field studies in the Balkans) and its traditional use in treating skin infection, we hypothesize that Oleum Hyperici does not contain hypericin, but does exhibit antibacterial activity against the most common cause of skin infection, *S. aureus*. In this research, organic and aqueous extracts of *H. perforatum* as well as commercial dietary supplements (tablet and liquid tincture) were compared to four Kosovar oil macerates in both chemical composition and antibacterial activity against *S. aureus* in order to investigate the contradictory nature of this traditional medicine.

Experimental methods {#s2}
====================

Collection and extraction of *H. perforatum* samples
----------------------------------------------------

Plant material was collected following standard guidelines for collection of wild specimens (WHO, [@B59]), while *H. perforatum* olive oil, sunflower oil, unknown oil A, and unknown oil B macerates were procured from local Prizren, Kosovo markets and households in this region by CQ and AH. All procured oils were reported to have been created in the traditional method, with the flowering aerial parts covered in vegetable oil and exposed to sunlight for 40 days. Voucher specimens were deposited at the Emory University Herbarium (Accession Numbers: [20051](20051) and [20091](20091)) and University of Prishtina Herbarium (BP-0002); digital copies of the specimens are accessible for viewing online via the SERNEC web portal (SERNEC, [@B51]). St. Johns Wort dietary supplements were purchased from a commercial vendor in Atlanta, Georgia, USA.

Shade-dried, aerial parts of *H. perforatum* were ground in a Thomas Scientific Wiley Mill (Swedesboro, NJ) through a 2 mm mesh. Dry powder (75 g) was transferred into an amber bottle and macerated in 750 mL of methanol (MeOH). The jug was wrapped in aluminum foil and left in the dark for 48 h, with agitation every 24 h. The MeOH extract was filtered through coarse and then fine filter paper. The marc was returned to the bottle and underwent a second 48 h maceration with 750 mL of MeOH and filtered as before. The filtrates were combined and evaporated using a rotary evaporator at \<40°C. The dried extract was re-dissolved in DI water, shell frozen, and freeze-dried overnight on a Labconco FreeZone 2.5 lyophilizer (Kansas City, MO). All solvents were acquired from Fisher Chemical, Certified ACS grade (Pittsburg, PA). The dry extract was scraped and transferred to scintillation vials wrapped in aluminum foil, and then stored at −20°C. All of the above procedures were conducted under aluminum foil tents to reduce ambient light exposure. An aqueous extract of the same material was also obtained by boiling 40 g of ground plant material in 400 mL DI water. This decoction was then strained through cheese cloth, double filtered, concentrated, freeze dried, and collected similarly to the above organic extract.

The commercial St. John\'s Wort dietary supplement extract was indicated to contain 300 mg of St. John\'s Wort Extract (flower) per capsule standardized to 0.3% hypericin. Three of these capsules were emptied and pooled, with 1.1 g of the contained powder from three capsules dissolved in 4.5 mL of MeOH in an Eppendorf tube. The solution was sonicated under aluminum foil for 30 min and centrifuged at 3,000 rpm for 15 min. The supernatant was transferred to a round-bottom flask and concentrated by removal of MeOH with a rotary evaporator. A 10 mL aliquot of the commercial liquid St. John\'s Wort flower buds and tops tincture (65--75% USP alcohol, indicating a 500 mg mL^−1^ herb equivalency) was concentrated with a rotary evaporator. Both commercial extracts were concentrated, stored and tested under reduced light. In total, eight samples were prepared for this experiment: a MeOH extract of the aerial parts (MAP), a MeOH extract of a tablet supplement (TS), a concentration of an EtOH liquid supplement (LS), a decoction of aerial parts (HAP), an olive oil macerate (OOO), a sunflower oil macerate (SOO), a macerate of unknown oil A (UOA), and another macerate of unknown oil B (UOB), Table [1](#T1){ref-type="table"}. Extracts were prepared for bacterial assays by dissolving in DMSO at 10 mg mL^−1^. Oil macerates and an olive oil control were prepared by first mixing with Tween20 (4:1), and then further diluting in media relevant to each bioassay (1:4), for a final 16% v/v oil emulsion. Tea tree essential oil was prepared at 10% v/v oil in an emulsion mixture (0.5% v/v Tween80 in DMSO) for use as a positive control.

###### 

Description of extracts made from the flowering aerial parts of *Hypericum perforatum*.

  **Extract abbreviation**   **Extraction material**                           **Extraction solvent**   **Extraction method**     **Percent yield**   **Vehicle**
  -------------------------- ------------------------------------------------- ------------------------ ------------------------- ------------------- --------------------------
  MAP                        Flowering Aerial Parts                            Methanol                 Maceration                28%                 DMSO
  TS                         Tablet Supplement ("from flower")                 Methanol                 Sonication                74%                 DMSO
  LS                         Liquid Supplement (from "flower buds and tops")   Already in EtOH          Rotary evaporation only   19%                 DMSO
  HAP                        Flowering Aerial Parts                            DI Water                 Decoction                 14%                 DMSO
  OOO                        Flowering Aerial Parts                            Olive Oil                40 Days in Sun            --                  Tween20 + relevant media
  SOO                        Flowering Aerial Parts                            Sunflower Oil            40 Days in Sun            --                  Tween20 + relevant media
  UOA                        Flowering Aerial Parts                            Unknown Oil A            40 Days in Sun            --                  Tween20 + relevant media
  UOB                        Flowering Aerial Parts                            Unknown Oil B            40 Days in Sun            --                  Tween20 + relevant media

*"--" denotes no % yield calculated on oil macerates acquired in Kosovo*.

Characterization by HPLC and LC-FTMS
------------------------------------

High performance liquid chromatography (HPLC) analysis was conducted on an Agilent Technologies ZORBAX Eclipse XDB-C18 250 × 4.6 mm, 5 μm column (Santa Clara, CA) with a compatible guard column at a column temperature of 25°C, monitored at 588 nm for extracts and 254 nm for oil macerates, adapting a method for a smaller column size by Liu (Liu et al., [@B26]). Runs were performed on an Agilent 1260 Infinity system using OpenLab CDS ChemStation. Reagents were HPLC grade and purchased from Fisher Scientific, with the exception of the Type 1 DI water, which was obtained from an EMD Millipore MILLI-Q water system (Billerica, MA). Mobile phases consisted of: (A) 20 mM ammonium acetate in water and ACN (9:1) and (B) ACN. The flow rate was 1 mL/min using samples at a 100 mg mL^−1^ concentration. Samples were prepared using HPLC and MS-grade MeOH, while oil macerates were analyzed after being dissolved in ethyl acetate (4:1). The injection volume was 5 μL, with gradient elution beginning at 50% B, increasing linearly from 2 to 22 min to 100% B, holding at this concentration for 9 min, before returning to initial conditions for 9 min.

The above parameters were also used for liquid chromatography Fourier transform mass spectrometry (LC-FTMS) experiments. Samples were run on a Shimadzu SIL-ACHT (Tokyo, Japan) and Dionex 3600SD HPLC pump (Sunnyvale, CA), with data acquired in MS mode scanning from an *m/z* of 150--1,500 on a Thermo Scientific LTQ-FT Ultra MS in both negative and positive ESI modes and processed with Thermo Scientific XCalibur 2.2 SP 1.48 software (San Jose, CA). The capillary temperature was 275.0°C, sheath gas of 60, source voltage of 5.0 kV and current 100.00 μA, and the capillary voltage −19.0 or +32.0 V, respectively. Peaks featuring putative compounds of the oil macerates were identified throughout the entire chromatogram and searched across the Dictionary of Natural Products (CRC Press) and Scifinder (Chemical Abstracts Service). High resolution masses of compounds were determined from the LC-FTMS data and searches conducted throughout the databases for all compounds identified in *H. perforatum* within a similar mass range. Additionally, an authentic standard of hyperforin DCHA (AdipoGen Corp., Sandiego CA) with ≥97% purity was analyzed by the previously described LC-FTMS method to aid in identification of this compound in the various *H. perforatum* preparations.

UV-Vis analysis
---------------

An Agilent Cary 50 UV-Vis Spectrometer was used to obtain UV-Vis spectra from 190 to 1,100 nm of the Oleum Hyperici samples and an olive oil control sample (Badia Extra Virgin Olive Oil). The data was collected and spectra analyzed using WinUV and Microsoft Excel.

Antibacterial evaluation
------------------------

### Growth inhibition assay

*S. aureus* cultures (described in Table [2](#T2){ref-type="table"}) were grown in Tryptic Soy Broth (TSB), with cation-adjusted Mueller Hinton broth (CAMHB) used for minimum inhibitory concentration (MIC) evaluation following standard Clinical and Laboratory Standards Institute (CLSI) methods (CLSI, [@B11]). To present a detailed view of the growth inhibitory activity across all samples tested, the MIC~50~ and MIC~90~, defined as the concentration required for at least 50 or 90% inhibition of growth, were both reported. The MIC~90~ is equivalent to the "MIC," defined as the concentration required for no visible growth in the well. All extracts and Oleum Hyperici samples prepared in this study were examined for MIC values against *S. aureus* strains representing the four accessory gene regulator (*agr*) alleles (*agr*I: AH1677, *agr*II: AH430, *agr*III: AH747, *agr*IV: AH1872) to observe potential trends in the inhibition of quorum sensing activity, MRSA strain LAC (AH1263), as well as a biofilm test strain (UAMS-1). All concentrations were tested in triplicate and repeated twice on different days. Controls included the vehicles (DMSO and olive oil emulsion), tea tree oil as an antibacterial oil control (Thursday Plantation, Australia), and antibiotics Vancomycin and Ampicillin (MP Biomedicals, Santa Ana, CA). Overnight cultures were standardized by optical density (OD) to 5 × 10^5^ CFU mL^−1^, and this was confirmed by plate counts of colonies. MIC~50~ and MIC~90~ values were assigned as described (Quave et al., [@B41]); this was determined by reading plates at an OD~600\ nm~ in a Cytation 3 multimode plate reader (BioTek, Winooski, VT) after 18 h incubation. In addition, MIC values of oil macerates were determined on an oil macerate volume/final well volume% basis (compared to μg mL^−1^ reporting for organic and aqueous extracts).

###### 

Summary of *S. aureus* strain characteristics.

  **Designation**   **Characteristics**                                                                                                       **References**
  ----------------- ------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------
  UAMS-1            Methicillin-sensitive *S. aureus* (MSSA), osteomyelitis isolate, PFT USA200                                               Cassat et al., [@B9]
  UAMS-929          *sarA* mutant of UAMS-1                                                                                                   Blevins et al., [@B5]; Beenken et al., [@B3]
  AH1263            Community-associated Methicillin resistant *S. aureus* (CA-MRSA), PFT USA300, *agr* group I; erythromycin sensitive LAC   Boles et al., [@B7]
  AH1677            *S. aureus agr* P3-YFP reporter, *agr* group I                                                                            Kirchdoerfer et al., [@B23]
  AH430             *S. aureus agr* P3-YFP reporter, *agr* group II                                                                           Kirchdoerfer et al., [@B23]
  AH1747            *S. aureus agr* P3-YFP reporter, *agr* group III                                                                          Kirchdoerfer et al., [@B23]
  AH1872            *S. aureus agr* P3-YFP reporter, *agr* group IV                                                                           Kirchdoerfer et al., [@B23]

### Quorum sensing inhibition assay

Quorum sensing activity was investigated as described (Quave and Horswill, [@B39]; Quave et al., [@B41]), using previously described (Kirchdoerfer et al., [@B23]) *S. aureus agr* P3-YFP reporter strains (AH1677, AH430, AH1747, AH1872; Table [2](#T2){ref-type="table"}). Briefly, overnight cultures grown in TSB supplemented with chloramphenicol (Cam) were diluted in fresh media with Cam to yield a final well starting inoculum of 5 × 10^5^ CFU mL^−1^. Black sided microtiter plates (Costar 3603) were incubated at 37°C with shaking (1,200 rpm) in a Stuart SI505 incubator (Bibby Scientific, Burlington, NJ) with a humidified chamber. Readings at OD~600\ nm~ and fluorescence (top reading, 493 excitation, 535 nm emission, gain 60) were taken after 18 h incubation. Controls included vehicles (DMSO and olive oil emulsion) and 224C-F2, a previously reported quorum sensing inhibitor (Quave et al., [@B41]). Inhibition of quorum sensing activity for oil macerates was determined on a volume/volume% basis (compared to μg mL^−1^ reporting for organic extracts). All extracts were tested at sub-inhibitory concentrations for growth, as determined in MIC assays.

To determine if any observed quorum sensing inhibition was influenced by potential growth inhibitory effects of the test agents, growth and fluorescence was monitored in parallel at multiple time points over a 20 h period. Furthermore, colony counts were taken at 18 h post incubation by serial diluting and plating aliquots of treatment and control groups in triplicate onto TSA using the drop-plate method (10 μL drops). Plates were incubated for 12 h, after which dilution factors with 3--30 colonies present per drop were counted to determine final CFU mL^−1^ for each group.

### Biofilm inhibition assay

Anti-biofilm activity was investigated using a human plasma protein-coated assay as previously described (Beenken et al., [@B4]; Quave et al., [@B40]) with *S. aureus* strains UAMS-1 and its isogenic *sarA* mutant (UAMS-929) as a biofilm deficient phenotypic control (Beenken et al., [@B3]). Briefly, following inoculation and addition of media (containing extract or vehicle alone) with a starting inoculum of 5 × 10^5^ CFU mL^−1^, 96-well plates (Falcon 35-1772) were incubated for 22 h at 37°C, washed with phosphate-buffered saline (PBS), fixed with ethanol, stained with crystal violet and rinsed in tap water. The stain was then eluted into the ethanol and was transferred to a new plate prior to quantification of the eluate at an OD~595\ nm~. The MBIC~50~ and MBIC~90~ are defined here as the minimum concentration of test agent required to inhibit 50 or 90% of biofilm formation, respectively. Controls included vehicles (DMSO and olive oil emulsion), tea tree oil as an oil comparison, and 220D-F2, a previously reported biofilm inhibitor (Quave et al., [@B40]).

Statistical analysis
--------------------

All tests were performed in triplicate and repeated on at least two different occasions. Heteroscedastic Student\'s *t-*tests were performed in Microsoft Excel and significance is denoted for all tests at ^\*^*P* \< 0.05, ^†^*P* \< 0.01, and ^‡^*P* \< 0.001.

Results {#s3}
=======

Growth inhibition
-----------------

HAP (aqueous extract of flowering aerial parts; see Table [1](#T1){ref-type="table"}) and MAP (methanol extract of flowering aerial parts) exhibited the strongest growth inhibitory activity across all *S. aureus* strains examined, with MIC~90~ values of 128 and 8--32 μg mL^−1^, respectively (Figure [3](#F3){ref-type="fig"}). The Oleum Hyperici samples (OOO, SOO, UOA, UOB; see Table [1](#T1){ref-type="table"}) did not exhibit growth inhibitory action at the concentration range examined (maximum of 0.512% v/v), with the exception of OOO, which exhibited an MIC~50~ of 0.512% v/v for one strain (AH1872). The commercial supplements (LS---liquid supplement and TS---tablet supplement) likewise exhibited only limited growth inhibitory activity; LS exhibited a MIC~50~ in the range of 64--256 μg mL^−1^ against three of the strains, and a MIC~90~ of 256 μg mL^−1^ against one. Dose-response data is presented in Figure [3](#F3){ref-type="fig"} and summary of MICs in Table [3](#T3){ref-type="table"}. These findings concerning the lack of strong antibacterial activity by the commercial supplements (TS and LS) and Oleum Hyperici samples were also confirmed by multiple OD readings over a 20 h period (Figure [4](#F4){ref-type="fig"}) and colony counts (Figure [5](#F5){ref-type="fig"}).

![Growth inhibitory activity of *H. perforatum* extracts against strains of *S. aureus*. Activity was detected by measure of optical density of wells (OD~600nm~) and is reported as percent of the vehicle control. Positive controls included antibiotics (ampicillin and vancomycin) and tea tree oil.](fmicb-08-01639-g0003){#F3}

###### 

Summary of bioactivity data.

  **Strain**          **Test**   **All reported in** μ**g mL**^**−1**^   **All reported in % v/v**                                                                     
  ------------------- ---------- --------------------------------------- --------------------------- ----- ----- ---- -------- ------- ------- ------- ------- ------- --
  UAMS-1              MIC~50~    8                                       256                         64    64    1    --       --      --      --      --      0.256   
                      MIC~90~    16                                      --                          256   128   2    --       --      --      --      --      0.512   
                      MBIC~50~   8                                       16                          16    512   NT   NT       0.008   0.016   0.016   0.004   0.008   
                      MBIC~90~   16                                      64                          128   --    NT   NT       --      --      --      --      --      
  AH1263              MIC~50~    4                                       512                         --    32    1    0.5      --      --      --      --      0.256   
                      MIC~90~    16                                      --                          --    128   2    8        --      --      --      --      0.512   
  AH1677 (*agr*I)     MIC~50~    4                                       512                         --    32    1    4        --      --      --      --      0.256   
                      MIC~90~    16                                      --                          --    128   2    8        --      --      --      --      0.512   
                      QSIC~50~   --                                      --                          --    --    NT   NT       --      0.512   --      --      NT      
  AH430 (*agr*II)     MIC~50~    8                                       --                          256   64    2    0.0625   --      --      --      --      0.128   
                      MIC~90~    16                                      --                          --    128   2    0.125    --      --      --      --      0.512   
                      QSIC~50~   --                                      32                          32    --    NT   NT       0.064   0.064   0.128   --      NT      
  AH1747 (*agr*III)   MIC~50~    8                                       --                          256   64    1    32       --      --      --      --      0.128   
                      MIC~90~    8                                       --                          --    128   2    32       --      --      --      --      0.512   
                      QSIC~50~   --                                      --                          --    --    NT   NT       --      --      --      --      NT      
  AH1872 (*agr*IV)    MIC~50~    8                                       --                          --    32    2    2        0.512   --      --      --      0.128   
                      MIC~90~    32                                      --                          --    128   2    2        --      --      --      --      0.512   
                      QSIC~50~   --                                      --                          --    --    NT   NT       0.256   0.512   0.512   0.512   NT      
                                                                                                                                                                       

*Minimum inhibitory concentration (MIC) values determined for each sample vs. each strain in this study; Minimum biofilm inhibitory concentration (MBIC) values determined for UAMS-1; Quorum sensing inhibitory concentration (50%) values (QSIC~50~) determined using agr reporter strains. TTO, tea tree oil; Van, vancomycin; Amp, ampicillin; --, not detected; NT, not tested. All organic extracts and antibiotics reported in units of μg mL^−1^; all oil macerates and oil controls reported as % v/v*.

![Impact of *H. perforatum* commercial supplements and Oleum Hyperici samples on growth and *agr* activity over 20 h as determined by optical density and fluorescence measures of four *S. aureus agr* reporters. Solid lines in the graphs denote OD; broken lines denote RFU. **(A)** Organic extracts and controls. **(B)** Oil macerates and controls. Test concentrations correspond with results on quorum sensing inhibition reported in Table [3](#T3){ref-type="table"}. Briefly, TS and LS were tested at 32 μg mL^−1^, DMSO (vehicle control) at eight concentrations from 0.02 to 0.64% v/v, and 224C-F2 (positive control) at eight concentrations from 0.5 to 64 μg mL^−1^, with results from the highest concentrations for the vehicle and positive control reported here. For oil macerate tests, OOO was tested at 0.512% v/v for *agr* I and III, 0.064% for *agr* II, and 0.256% for *agr* IV; SOO was tested at 0.512% for *agr* I, III, and IV, 0.064% for *agr* II; UOA was tested at 0.512% for *agr* I, III, and IV, 0.0128% for *agr* II; UOB was tested at 0.512% for *agr* I, III, and IV, 0.0128% for *agr* II. Lastly, Olive Oil was tested at 8 concentrations from 0.004 to 0.512% and the highest concentration is reported here.](fmicb-08-01639-g0004){#F4}

![Impact of *H. perforatum* commercial supplements and Oleum Hyperici samples on *S. aureus* growth, as determined by colony counts. To further investigate whether the decreased level of quorum sensing activity in extracts and oil macerates was due to any potential growth inhibitory effects, the number of colony forming units (CFU) per mL of broth was determined at 18 h. Test concentrations correspond to those reported in Figure [4](#F4){ref-type="fig"}. Significant differences between the vehicle control and treatment groups are denoted as ^\*^*P* \< 0.05, ^†^*P* \< 0.01, and ^‡^*P* \< 0.001.](fmicb-08-01639-g0005){#F5}

Quorum sensing inhibition
-------------------------

Modest inhibition of quorum sensing (QS) was observed in three (OOO, SOO, UOA) of the oil macerate samples against the *agr*II reporter (AH430), with QSIC~50~ values of 0.064--0.128% v/v, Table [3](#T3){ref-type="table"}. All four oil samples inhibited QS in the *agr*IV isolate (QSIC~50~ 0.256--0.512% v/v); SOO also inhibited QS in *agr*I (AH1677) at an IC~50~ of 0.512% v/v. Two of the organic extracts (TS and LS) inhibited quorum sensing (QSIC~50~ of 32 μg mL^−1^ against AH430), but this activity did not exhibit a dose-dependent improvement in activity with an increase in test concentration, Figure [6](#F6){ref-type="fig"}. Time-dependent examination of OD and relative fluorescence units (RFU) activity over a 20 h period revealed that the observed quorum sensing inhibitory activity was not an artifact of growth inhibitory effects of the samples. Colony counts at 18 h of incubation also confirmed this, with the exception of a minor---but statistically significant---difference in the number of colonies between the olive oil control and SOO and OOO samples for the *agr*II reporter strain and also between the DMSO vehicle control and LS and TS in the *agr*IV reporter strain (Figure [5](#F5){ref-type="fig"}). None of these exhibited a lower number of colonies in comparison to the vehicle controls in more than one strain.

![Impact of *H. perforatum* extracts on *S. aureus* quorum sensing, as detected by *agr* reporters. Activity was detected by measure of fluorescence and is reported as percent of the vehicle control. The botanical extract "224C-F2" (a known quorum quencher) was used as the positive control (Quave et al., [@B41]).](fmicb-08-01639-g0006){#F6}

Impact on biofilm formation
---------------------------

All of the *H. perforatum* extracts (oils and organic extracts) exhibited some degree of inhibition of biofilm formation, Table [3](#T3){ref-type="table"} and Figure [7](#F7){ref-type="fig"}. Among the organic extracts, MAP was the most potent (MBIC~50~ of 8 μg mL^−1^), however, this extract also exhibited growth inhibitory effects (MIC~50~ of 8 μg mL^−1^). In all of the organic extracts, the growth inhibitory effects of the extracts were responsible for the diminished level of biofilm formed.

![Impact of *H. perforatum* extracts on *S. aureus* biofilm formation, as detected by static microtiter plate crystal violet assay. USA 200 isolate UAMS-1 and its isogenic *sarA* mutant (UAMS-929) were used in the biofilm assay. **(A)** Images of crystal violet stained biofilm in 96-well plates. The optical density (OD~595\ *nm*~) of the biofilm eluent is reported as percent of the wild type control (UAMS-1) for the **(B)** organic and **(C)** oil extracts. Significance is denoted as ^\*^*P* \< 0.05, *P* \< 0.01, and ^‡^*P* \< 0.001.](fmicb-08-01639-g0007){#F7}

With regards to the traditional oil macerates, biofilm inhibition was observed in all four oils (OOO, SOO, UOA, UOB) with MBIC~50~ values ranging from 0.004 to 0.016% v/v. This inhibition was observed in the absence of any growth inhibitory activity (max test concentration of 0.512% v/v).

Chemical analysis
-----------------

Percent yields for extracts are reported in Table [1](#T1){ref-type="table"}. Analysis of the extracts by HPLC and LC-FTMS revealed the presence of hypericin in the organic and aqueous extracts (MAP, TS, LS, HAP), but not in the oil macerate samples (OOO, SOO, UOA, UOB), Tables [4](#T4){ref-type="table"}, [5](#T5){ref-type="table"}. Exact mass data of a total of 46 compounds was collected (Table [5](#T5){ref-type="table"}).

###### 

Summary of key chemical data.

        **Hyperforin**   **Hypericin**        
  ----- ---------------- --------------- ---- ---
  MAP   \+               \+              \+   −
  TS    \+               \+              \+   −
  LS    \+               \+              \+   −
  HAP   \+               \+              \+   −
  OOO   \+               −               −    −
  SOO   \+               −               −    −
  UOA   \+               \+              −    −
  UOB   \+               −               −    −

*Presence of hyperforin (**14**) or hypericin (**18**) in study samples as determined by mass spectrometry. MAP, methanol extract of flowering aerial parts; TS, commercial tablet supplement; LS, commercial liquid supplement; HAP, aqueous extract of flowering aerial parts; OOO, olive oil macerate of flowering aerial parts; SOO, sunflower oil macerate of flowering aerial parts; UOA, unknown oil A macerate of flowering aerial parts; UOB, unknown oil B macerate of flowering aerial parts; see Table [1](#T1){ref-type="table"} for full details*.

###### 

Mass spectrometry (MS) and MS/MS analysis of the peak data for oil macerates as reported in Figure [8](#F8){ref-type="fig"}.

  **Peak**   **RT (min)**   **RPA**      **m/z**                                                              **Formula**      **Δ ppm**   **MS/MS**                                                                                            **Putative match**
  ---------- -------------- ------------ -------------------------------------------------------------------- ---------------- ----------- ---------------------------------------------------------------------------------------------------- -------------------------------------------------
  **OOO**                                                                                                                                                                                                                                       
  12         12.8           0.6          551.37436                                                            C~35~H~51~O~5~   1.3         482.2488, 441.4178, 411.4015, 343.3420, 329.2700, 261.1974                                           Perforatumone
  13         13.4           0.3          **535.3791** \[M-H\]^−^, 1071.7705 \[2M-H\]^−^                       C~35~H~51~O~4~   0.2         466.3142, 397.3240, 383.3057, 315.2947                                                               Isomer of hyperforin
  14         13.8           2.1          **535.3803** \[M-H\]^−^, 1071.7662 \[2M-H\]^−^                       C~35~H~51~O~4~   2.1         466.3142, 383.3057, 315.2947                                                                         Hyperforin
  16         14.6           1.0          **277.2169** \[M-H\]^−^, 555.4411 \[2M-H\]^−^                        C~18~H~29~O~2~   0.7         259.3089, 230.3098                                                                                   Isomer of linolenic acid
  17         15.0           0.2          277.2169, **549.3946**                                               na               na          480.3090, 397.3433, 329.3007                                                                         No matches
  21         18.9           46.0         **279.2329** \[M-H\]^−^, 559.4751 \[2M-H\]^−^                        C~18~H~31~O~2~   1.1         261.3105                                                                                             Isomer of octadecadienoic acid
  24         19.9           3.6          **413.2928**, 633.5133                                               na               na          395.3275, 369.4152, 343.3766, 275.3397, 261.3305                                                     No matches
  34         22.6           0.2          279.2332, 401.2917, 415.3075, **635.5284**                           na               na          566.3971, 497.2485, 483.3696, 415.3459, 413.4047                                                     No matches
  37         23.0           16.6         **255.2330** \[M-H\]^−^, 511.4750 \[2M-H\]^−^                        C~16~H~31~O~2~   1.2         237.3247                                                                                             Isomer of hexadecanoic acid
  40         23.7           28.5         **281.2488** \[M-H\]^−^, 563.5076 \[2M-H\]^−^                        C~18~H~33~O~2~   1.3         281.3895, 263.3492                                                                                   Isomer of octadecadienoic acid
  **SOO**                                                                                                                                                                                                                                       
  12         12.9           0.4          551.3738                                                             C~35~H~51~O~5~   0.9         482.2240, 441.4119, 411.3747, 399.3005, 329.2698, 261.2464                                           Constitutional isomer of furohyperforin
  13         13.5           0.03         535.3788                                                             C~35~H~51~O~4~   0.5         466.3193, 383.2970, 315.2576                                                                         Isomer of hyperforin
  14         13.9           0.9          535.37933                                                            C~35~H~51~O~4~   1.1         466.3194, 397.3143, 383.2970, 315.2576                                                               Hyperforin
  16         14.7           0.6          **277.21695** \[M-H\]^−^, 555.44167 \[2M-H\]^−^                      C~18~H~29~O~2~   0.7         259.27758, 233.31211                                                                                 Isomer of linolenic acid
  21         19.0           34.9         **279.2329** \[M-H\]^−^, 559.4750 \[2M-H\]^−^                        C~13~H~31~O~2~   1.1         260.3311, 234.3294                                                                                   Isomer of octadecadienoic acid
  24         20.0           2.9          413.2923, **633.5119**                                               na               na          589.573                                                                                              No matches
  34         22.7           0.1          415.30800, **635.42920**                                             na               na          415.4052, 397.3306, 371.3948, 357.4052, 345.4222, 333.1057, 315.3957                                 No matches
  37         23.2           16.3         **255.2330** \[M-H\]^−^, 511.4749 \[2M-H\]^−^                        C~16~H~31~O~2~   1.2         255.3141, 237.3085                                                                                   Isomer of hexadecanoic acid
  40         23.9           42.3         281.2488 \[M-H\]^−^, **563.5073** \[2M-H\]^−^                        C~18~H~33~O~2~   1.3         300.1513, 283.1704                                                                                   Isomer of octadecadienoic acid
  **UOA**                                                                                                                                                                                                                                       
  7          9.3            0.27         295.2275, **481.3314**                                               C~31~H~45~O~4~   0.5         437.4552, 233.1511                                                                                   Constitutional isomers of hyperibine J
  12         12.8           0.18         551.37370                                                            C~35~H~51~O~5~   0.6         482.2713, 412.3792, 411.3806                                                                         Constitutional isomers of furohyperforin
  13         13.4           0.03         535.37880                                                            C~35~H~51~O~4~   0.5         466.2948, 397.3213, 383.3018, 315.2775                                                               Isomer of hyperforin
  14         13.8           1.2          **535.7926** \[M-H\]^−^                                              C~35~H~51~O~4~   0.8         466.2948, 383.3018, 315.2775                                                                         Hyperforin
  16         14.6           0.59 (1.2)   **277.2169** \[M-H\]^−^, 555.44112 \[2M-H\]^−^                       C~18~H~29~O~2~   0.2         259.3406, 233.3297                                                                                   Isomer of linolenic acid
  21         18.7           34.6         **279.2329** \[M-H\]^−^, 559.4747 \[2M-H\]^−^                        C~18~H~31~O~2~   0.5         260.3058, 234.3110                                                                                   Isomer of octadecadienoic acid
  24         19.9           5.1          **413.2921**, 633.5118                                               na               na          343.3614, 275.3439                                                                                   No matches
  29         21.3--23.1     18.0         661.5099, **675.5257**                                               na               na          657.8013, 631.7033, 420.5482, 303.1914, 255.3595                                                     See peak **19**
  36         23.1--23.6     8.9          255.2337, 511.4769, 611.5306, 661.5103, **871.7505**                 na               na          853.6913, 829.0806, 255.3568                                                                         No matches
  40         23.9           25.9         **281.2491** \[M-H\]^−^, 563.5091 \[2M-H\]^−^, 897.7645              C~18~H~33~O~2~   1.0         262.3976, 236.2134, 198.1185                                                                         Isomer of octadecadienoic acid
  **UOB**                                                                                                                                                                                                                                       
  10         11.3           0.31         471.3473                                                             C~30~H~47~O~4~   0.5         423.4483, 405.4416, 393.4567                                                                         Astrantiagenin E
  12         12.7           0.11         **551.3738**, 675.5210                                               C~35~H~51~O~5~   0.6         482.2245, 411.3920, 399.3053, 343.3059, 329.2852, 261.2125                                           Constitutional isomer of furohyperforin
  14         13.6           0.17         **535.3789**, 675.5210                                               C~35~H~51~O~4~   0.8         466.2634, 397.3361, 383.2967, 315.2905                                                               Hyperforin
  19         17.3--18.3     2.2          661.5062, **675.5217**                                               na               na          678.6637, 659.5819, 631.4965, 617.5931                                                               No matches
  21         18.7           5.2          **279.2329** \[M-H\]^−^, 559.4744 \[2M-H\]^−^, 675.5237, 895.7440    C~18~H~31~O~2~   1.0         260.3058, 234.3120                                                                                   Isomer of octadecadienoic acid
  36         19.2--23.2     22.3         661.5062, **675.5217**                                               na               na          659.7014, 633.7161, 617.6087                                                                         No matches
  40         23.5           62.6         **281.2491** \[M-H\]^−^,563.5091 \[2M-H\]^−^, 897.7619               C~18~H~33~O~2~   1.2         279.3965, 271.2765, 223.2382                                                                         Isomer of octadecadienoic acid
  **MAP**                                                                                                                                                                                                                                       
  1          6.0            1.1          569.3866                                                             na               na          500.3059, 431.2675, 383.3261, 347.3187                                                               No matches
  3          8.0            7.4          **467.3181** \[M-H\]^−^, 935.6448 \[2M-H\]^−^                        C~30~H~43~O~4~   0.1         398.4204, 383.4447, 329.3192, 271.2862                                                               Isomer of hyperfirin
  4          8.8            1.2          551.3762                                                             C~35~H~51~O~5~   1.6         482.3014, 411.4000, 399.3306, 329.2943                                                               Constitutional isomer of furohyperforin
  7          9.2            5.0          **481.3339** \[M-H\]^−^, 963.6766 \[2M-H\]^−^                        C~31~H~45~O~4~   1.5         412.4372                                                                                             Constitutional isomer of hyperibine J
  12         13.1           2.2          551.3761                                                             C~35~H~51~O~5~   3.6         482.2594, 411.4157                                                                                   See peak **4**
  13         13.5           1.3          **535.3813** \[M-H\]^−^, 1071.7733 \[2M-H\]^−^                       C~35~H~51~O~4~   2.0         466.3979, 397.4284, 383.4537, 315.4665                                                               Isomer of hyperforin
  14         14.0           29.9         **535.3806** \[M-H\]^−^, 1071.7706 \[2M-H\]^−^                       C~35~H~51~O~4~   2.3         466.4227, 397.4148, 383.4798, 315.4864                                                               Hyperforin
  15         14.6           1.0          **549.3972** \[M-H\]^−^, 1099.8104 \[2M-H\]^−^                       C~36~H~53~O~4~   2.2         480.3700, 411.4376, 397.3677, 329.3505, 313.3432 289.2536                                            Isomer of adhyperforin
  17         15.3           11.2         **549.3970** \[M-H\]^−^, 1099.8047 \[2M-H\]^−^                       C~36~H~53~O~4~   4.1         480.3942, 411.3993, 397.3756, 329.3478, 313.3410                                                     See peak **15**
  18         16.3           1.2          503.0788                                                             C~30~H~15~O~8~   1.0         459.24370                                                                                            Hypericin
  20         17.8           5.9          **535.3812** \[M-H\]^−^, 1071.7714 \[2M-H\]^−^                       C~35~H~51~O~4~   3.7         397.4702, 275.2561                                                                                   Constitutional isomer of hyperforin
  22         19.3           4.8          **549.3972** \[M-H\]^−^, 1099.8042 \[2M-H\]^−^                       C~36~H~53~O~4~   4.2         411.4589, 289.2577                                                                                   See peak **15**
  23         19.5           1.1          **535.3809**\[M-H\]^−^, 1071.7760\[2M-H\]^−^                         C~35~H~51~O~4~   3.2         397.3486, 275.1979                                                                                   See peak **20**
  25         20.6           2.3          543.3368                                                             na               na          515.4505, 473.4408, 432.3971, 405.3768                                                               No matches
  26         20.8           2.1          583.3665                                                             na               na          514.3254, 445.4010, 429.4055, 397.3282                                                               No matches
  28         21.0           1.1          549.3973, 583.3668, 613.3775, **627.3932**                           na               na          609.4827, 558.4290                                                                                   No matches
  30         21.9           1.3          557.3520                                                             na               na          539.4671, 413.4827, 497.4655, 469.4883, 347.3743                                                     No matches
  32         22.3           2.6          509.3286                                                             C~32~H~45~O~5~   1.4         481.4579, 465.4379, 439.3066, 371.3111, 327.3694                                                     Isomer of polyprenylated acylphloroglucinol
  41         24.1           1.4          597.3812                                                             na               na          539.4692, 469.3719, 455.3666, 399.3432, 343.2971                                                     No matches
  43         24.7           2.0          **597.3829**, 611.3987                                               na               na          455.3906, 399.3456, 343.2941                                                                         See peak **41**
  **TS**                                                                                                                                                                                                                                        
  2          6.9            2.3          521.0879                                                             C~30~H~43~O~4~   0.1         477.2168                                                                                             Protopseudohypericin
  5          8.9            1.1          519.0724                                                             C~30~H~15~O~9~   0.1         503.3031                                                                                             Isopseudohypericin
  9          11.3           19.7         553.3904                                                             na               na          484.3227, 415.3904, 401.3363, 338.2878                                                               No matches
  12         13.1           6.1          551.3752                                                             C~35~H~51~O~5~   1.5         482.3489, 455.4689, 399.3075, 330.2504                                                               Constitutional isomer of furohyperforin
  13         13.4           2.4          535.3799                                                             C~35~H~51~O~4~   0.6         466.2862, 397.3600, 383.3395, 315.3039, 275.2309                                                     Isomer of hyperforin
  14         14.1           5.0          **535.3810** \[M-H\]^−^, 1071.7718 \[2M-H\]^−^                       C~35~H~51~O4     3.2         466.2948, 383.3485, 315.3024                                                                         Hyperforin
  17         15.2           6.1          **549.3968** \[M-H\]^−^, 1099.8028 \[2M-H\]^−^                       C~36~H~53~O~4~   1.9         480.3235, 397.3463, 329.3124                                                                         Isomer of adhyperforin
  18         16.4           2.4          **503.0778**, 551.3753                                               C~30~H~15~O~8~   0.5         503.2111, 459.2324                                                                                   Hypericin
  20         17.7           5.0          **535.3807** \[M-H\]^−^, 1071.7719 \[2M-H\]^−^                       C~35~H~51~O4     2.8         397.3674, 275.2193                                                                                   Constitutional isomer of hyperforin
  22         19.1           2.3          549.3966                                                             C~36~H~53~O~4~   3.0         411.3998, 289.2541                                                                                   See peak **17**
  23         19.4           1.9          **535.3806**, 559.4747                                               C~35~H~51~O~4~   3.0         397.3598, 275.2287                                                                                   See peak **20**
  26         20.8           3.5          583.3658                                                             na               na          539.3626, 495.3746, 471.4266, 455.3294, 441.3578, 427.3751, 385.3207, 345.3529, 329.3006, 275.2133   No matches
  28         21.0           1.5          627.3940                                                             na               na          595.5207, 567.5077, 558.3551, 484.4406                                                               No matches
  32         22.3           1.9          509.3286                                                             C~32~H~45~O~5~   1.7         481.4253, 465.3411, 439.3995, 398.3324, 371.3304                                                     Isomer of polyprenylated acylphloroglucinol
  33         22.5           0.4          643.3877                                                             na               na          625.3742, 599.4978, 583.5160, 574.4302, 505.3105                                                     No matches
  37         23.6           33.0         511.4748                                                             na               na          435.4601                                                                                             No matches
  43         24.7           3.7          611.3991                                                             na               na          593.5766, 551.4913, 542.3932                                                                         No matches
  45         31.8           1.9          **283.2642** \[M-H\]^−^, 567.5364 \[2M-H\]^−^                        C~18~H~35~O~2~   0.1         265.3776                                                                                             Isomer of octadecanoic acid
  **LS**                                                                                                                                                                                                                                        
  1          5.7            1.6          569.3851                                                             na               na          273.1406, 257.1530, 229.1662, 179.0143, 151.0151                                                     No matches
  4          8.8            0.7          551.3753                                                             C~35~H~51~O~5~   1.0         482.2749, 411.3920, 383.3228, 329.2915, 275.2239                                                     Constitutional isomers of furohyperforin
  8          10.3           1.1          569.3854                                                             na               na          na                                                                                                   No matches
  9          11.1           1.2          553.3907                                                             na               na          485.3576, 416.3804, 402.3450, 334.2963                                                               No matches
  11         11.8           1.6          467.3170                                                             C~30~H~43~O~4~   0.3         398.2772, 329.2860, 287.2419, 275.2608, 219.1733                                                     Isomer of hyperfirin
  12         12.9           2.4          551.3753                                                             C~35~H~51~O~5~   2.2         482.2471, 411.3996                                                                                   Constitutional isomer of furohyperforin
  13         13.2           1.3          **535.3805** \[M-H\]^−^,1071.7709 \[2M-H\]^−^                        C~35~H~51~O~4~   1.2         466.3801, 397.3877, 383.3733, 315.3414, 275.2349                                                     Isomer of hyperforin
  14         13.8           28.2         **535.3810** \[M-H\]^−^, 1071.7718 \[2M-H\]^−^                       C~35~H~51~O~4~   3.3         466.4120, 383.3845, 315.3482                                                                         Hyperforin
  15         14.4           1.2          **549.3965** \[M-H\]^−^, 1099.8062 \[2M-H\]^−^                       C~36~H~53~O~4~   1.6         480.2871, 411.3738, 397.3655, 329.3298, 313.3076, 289.2431                                           Isomer of adhyperforin
  17         15.0           11.4         **549.3970** \[M-H\]^−^, 1099.8034 \[2M-H\]^−^                       C~36~H~53~O~4~   3.7         480.2986, 397.3735, 329.3245                                                                         See peak **15**
  18         16.2           1.3          503.0778                                                             C~30~H~15~O~8~   0.6         487.2185, 459.2460                                                                                   Hypericin
  20         17.6           8.7          **535.3809** \[M-H\]^−^, 1071.7711 \[2M-H\]^−^                       C~35~H~51~O~4~   3.0         397.4060, 275.2363                                                                                   Constitutional isomer of hyperforin
  22         19.0           4.7          **549.3966** \[M-H\]^−^, 1099.8046 \[2M-H\]^−^                       C~36~H~53~O~4~   3.1         411.3572, 289.2496                                                                                   see peak **15**
  23         19.2           3.3          **535.3808** \[M-H\]^−^, 1071.7730 \[2M-H\]^−^                       C~35~H~51~O~4~   2.9         397.3746, 275.2188                                                                                   See peak **20**
  27         20.7           1.8          **549.3967** \[M-H\]^−^, 1099.8068 \[2M-H\]^−^                       C~36~H~53~O~4~   3.5         411.3706, 289.2387                                                                                   See peak **15**
  31         22.1           1.8          509.3289, **583.3661** \[M-H\]^−^, 637.4499, 1167.7499 \[2M-H\]^−^   na               na          539.4567, 471.4214                                                                                   No matches
  35         23.0           3.6          **367.2647** \[M-H\]^−^, 735.5381 \[2M-H\]^−^                        na               na          177.1379                                                                                             No matches
  38         23.3           0.9          523.3455, **597.3814**, 815.5020                                     na               na          553.4625, 528.3395, 495.4520, 471.4037                                                               No matches
  39         23.9           1.3          **255.2331** \[M-H\]^−^, 511.4743 \[2M-H\]^−^                        C~16~H~31~O~2~   0.2         242.1994                                                                                             Hexadecanoic acid
  43         24.7           2.8          551.3789, 597.3834, **611.4005**, 833.6381, 1163.8008                na               na          na                                                                                                   No matches
  44         25.6           1.1          **535.3809**, 625.4123                                               C~35~H~51~O~4~   2.9         397.3663, 275.2371                                                                                   See peak **20**
  46         33.2           1.2          **551.3754** \[M-H\]^−^, 1103.7625 \[2M-H\]^−^                       C~35~H~51~O5     2.2         508.5036, 456.4861                                                                                   See peak **12**
  **HAP**                                                                                                                                                                                                                                       
  3          7.7            7.0          **467.3162**, 567.3691, 935.6430                                     C~30~H~43~O~4~   0.4         398.2960                                                                                             Isomer of hyperfirin
  6          8.9            7.3          **481.3326** \[M-H\]^−^, 963.6747\[2M-H\]^−^                         C~31~H~45~O~4~   0.3         412.3196                                                                                             Constitutional isomer of hyperibine J
  12         12.8           3.2          551.3746                                                             C~35~H~51~O~5~   0.4         482.2764, 413.3273, 383.3141, 329.2978                                                               Constitutional isomer of furohyperforin
  14         13.8           35.7         **535.3810** \[M-H\]^−^, 1071.7711 \[2M-H\]^−^                       C~35~H~51~O~4~   1.7         466.2689, 451.3754, 383.3375, 315.3061                                                               Hyperforin
  15         14.3           0.6          549.3955                                                             C~36~H~53~O~4~   0.6         480.2824, 397.3177, 329.3075, 313.2955, 289.2541                                                     Isomers of adhyperforin
  17         15.0           15.6         **549.3967** \[M-H\]^−^, 1099.8029 \[2M-H\]^−^                       C~36~H~53~O~4~   3.3         480.2938, 397.3234, 329.3068                                                                         Isomer of adhyperforin
  18         16.2           1.5          503.0774                                                             C~30~H~15~O~8~   0.2         487.1872, 459.2382                                                                                   Hypericin
  23         19.2           0.8          535.3800                                                             C~35~H~51~O~4~   1.3         397.34501, 275.19977                                                                                 Constitutional isomer of hyperforin
  25         20.3           2.1          529.3198, **543.3355**                                               na               na          515.4520, 499.4560, 473.4428, 432.3554, 405.3853                                                     No matches
  28         20.8           1.0          627.3928                                                             na               na          609.5030, 581.5090, 567.5005, 558.3908                                                               No matches
  30         21.6           1.7          543.3355, **557.3512**                                               na               na          na                                                                                                   No matches
  32         22.1           3.3          509.3287                                                             C~32~H~45~O~5~   1.4         481.4410, 465.4290, 439.3782, 398.3118, 371.3374                                                     Isomer of polyprenylated acylphloroglucinol
  38         23.3           1.3          523.3443                                                             C~33~H~47~O~5~   1.4         495.4596, 479.4419, 439.4268, 412.3792, 385.3166, 369.4376, 341.3946, 329.3829                       Isomer of polyprenylated bicyclo\[3.3.1\]nonene
  42         24.4           1.2          613.3777, **627.3943**                                               na               na          583.4786                                                                                             No matches
  43         24.6           4.1          597.3826, **611.4005**, 807.6203                                     na               na          552.5200, 551.4894                                                                                   No matches

*RT, retention time; RPA, relative percent abundance, based on peak area. Bold m/z values are parent ions for the reported MS/MS fragments when more than one ion present*.

LC-FTMS analysis of the oil samples revealed the presence of 12 distinct compounds, only four of which were found in all four samples, Figure [8](#F8){ref-type="fig"}; this included the putative compounds: constitutional isomer of furohyperforin (**12**), hyperforin (**14**), and isomers of octadecadienoic acid (**21** and **40**), Table [5](#T5){ref-type="table"}. Compounds **21** and **40** had the highest relative abundance of all components of the oil macerate samples. Peaks **13, 14, 20, 23**, and **44** all had m/z of 535.38, by comparison of the retention times and mass spectra with that of an authentic standard it was determined that **14** was hyperforin. Peaks **13** and **14** also have similar MS^2^ fragments. Since hyperforin has been identified as having 3 tautomers, 1,3 diketone and two enols, the authors have assigned **13** as the enol form. This tautomerization was shown to occur on HPLC columns at a pH of 2.5, very similar to the pH of the 0.1% formic acid mobile phases used in these HPLC methods (Fourneron and Naït-Si, [@B15]; Lee et al., [@B25]). Peaks **20**, **23**, and **44** all have base peaks with m/z 535.38; however, the MS^2^ is not consistent with hyperforin and these peaks have been assigned as constitutional isomers of hyperforin.

![Characterization of *H. perforatum* extracts by LC-FTMS. Chromatograms of organic and oil extractions of *H. perforatum* are reported; peak numbers correspond to Table [5](#T5){ref-type="table"}.](fmicb-08-01639-g0008){#F8}

Analysis of the organic and aqueous samples revealed the presence of six compounds common in all four samples: **12, 14**, isomer of adhyperforin (**17**), hypericin (**18**), hyperforin (**23**), and **43**; compounds **12** and **14** were the only ones also present in the oil samples. Peak **20** (an isomer of hyperforin) was present in all of the organic extracts (TS, LS, MAP), but absent in the aqueous extract (HAP).

Discussion {#s4}
==========

Chemistry
---------

Through LC-FTMS analysis of different *H. perforatum* formulations, we have demonstrated that the traditional oil macerate (Oleum Hyperici), used in topical applications for skin and soft tissue infections throughout the Balkans, contains the bioactive compound hyperforin, but not the photosensitizing compound, hypericin. In contrast, the MeOH, aqueous, and commercial supplement extracts all featured both hypericin and hyperforin. The composition difference between the two classes of sample in this study is most likely due to the methods of their extractions, with photo-extraction in an oil solution yielding very different compounds than a low-light organic or aqueous extract. This supports field observations of a lack of reported photosensitive reactions among users of the oil for topical skin care.

However, in contrast to our findings concerning the chemistry of Oleum Hyperici, Miraldi et al. ([@B31]) presented a different case, in that hyperforin, adhyperforin, hyperevolutin A and B, hypericin and pseudohypericin are entirely absent from preparations of this oil macerate. These results were found in oil macerates produced by 15 days of sun exposure---as opposed to 40, as described in ethnobotanical research (Mustafa et al., [@B34]). Nevertheless, the presence of hyperforin---a photolabile, oxidation prone phloroglucinol derivative---in a formulation which relies on extended periods of sun exposure presents some additional questions. Mainly, how is it possible that this compound remains stable in this traditional preparation? One potential explanation based on the work of Boskou ([@B8]) might be that the abundant terpenoids in the oil itself could be stabilized in light and heat, and in turn, act as sacrificial reducing agents for the ROS preventing the eventual oxidation of hyperforin into furohyperforin. While this change can be evaluated by an increase in the oil\'s viscosity due to an increase ratio of palmitic to linoleic acid, further experimentation and research is required to evaluate this change in the oil. The degradation of hyperforin follows first order kentics yielding a tautomeric mixture of 2-methyl-3-hydroxy-4-(1-oxo-2-methyl-1-propyl)-1,5-dioxo-6-(3methyl-1-but-2-enyl)-2-cyclohexeneand 2-methyl-1,3,5-trioxo-4-(1-hydroxy-2-methyl-1-propylene)-6-(3-methyl- 1-but-2-enyl)-cyclohexane via three Norrish type II reactions (D\'Auria et al., [@B12]). The oil or other compounds in the oil macerate may be absorbing some of the light necessary for the Norrish reactions to occur, thus preventing the hyperforin from decomposing. An analysis of a purchased olive oil sample by UV-Vis showed a strong absorption band at 299--302 nm (data not shown) and the spectrum below this wavelength was very noisy indicating that the oil itself has a strong and complex absorbance in this range. Published UV-Vis spectra of hyperforin show a λ of 298--310 nm depending on the solvent (Vuong et al., [@B57]; Ng et al., [@B35]). Based on this analysis, the olive oil itself is absorbing UV light in the range that is necessary to degrade the hyperforin and thus protecting the compound in the oil maceration.

Other factors that can contribute the variations in the oil macerates include the natural variation in the *H. perforatum* plant material used to make the preparations in the different studies. These variations are known to influence both the chemical composition and bioactivity of *Hypericum* products (Marrelli et al., [@B28]). Variations in secondary metabolite concentrations could be the result of the botanical source material being grown in differing climates or having been exposed to differing stressors, such as herbivory, infection, or drought. Due to such potential variation, any commercial preparation of *H. perforatum* should be standardized to established marker compounds using accepted analytical methods, those published by AOAC \[AOAC Stakeholder Panel on Strategic Foods Analytical Methods (SPSFAM), [@B2]\].

Bioactivity
-----------

We demonstrated with our bioactivity findings that while the traditional oil macerates (Oleum Hyperici) do not exhibit strong anti-staphylococcal growth inhibitory activity as is noted in the organic and aqueous preparations of the flowering aerial parts, they do exhibit biofilm inhibitory properties at sub-inhibitory concentrations for growth and exhibit modest quorum quenching effects against three of the four accessory gene regulator (*agr*) alleles. The quorum sensing inhibitory activity of the ethyl acetate extract of a related species (*H. connatum*) has been reported against *Pseudomonas aeruginosa* (Fratianni et al., [@B16]). In previous work, we assessed the capacity of *H. perforatum* and many other Mediterranean species to inhibit production of delta-hemolysin, a transcriptional product controlled by the *agr* system, however the ethanolic extract of *H. perforatum* stems exhibited only mild inhibitory activity (36% inhibition of delta-toxin production; Quave et al., [@B42]). Thus, to the best of our knowledge, this is the first report of a *Hypericum* species extract or formulation inhibiting quorum sensing at a level \>50% against *S. aureus*.

The growth inhibitory activity of the extracts containing hypericin (MAP, TS, LS, HAP) was unsurprising as hypericin is reported to be the major growth inhibitory antibacterial agent for this species (Saddiqe et al., [@B44]; Yow et al., [@B61]). In addition to numerous studies on the growth inhibitory properties of *H. perforatum* extracts, a few have also examined their anti-biofilm potential. Extracts of the adventitious roots have demonstrated anti-biofilm activity against the fungus *Malassezia furfur* (Simonetti et al., [@B52]). With regards to anti-biofilm activity in bacteria, hyperforin and its hydrogenated analog have been shown to inhibit planktonic and biofilm cultures of *S. aureus* and *E. faecalis* (Schiavone et al., [@B49]). A suite of *Hypericum* spp. secondary metabolites were found to exhibit anti-biofilm activities against *S. aureus* and *S. epidermidis*, one of which---a phloroglucinol from *H. punctatum*---had an MBIC (no detectable biofilm formation) of just 1.95 μg mL^−1^ (Sarkisian et al., [@B46]).

In our analyses, we found that the organic, aqueous, and oil extracts all exhibited some level of biofilm inhibition against *S. aureus*. However, it was difficult to gain an accurate assessment of the inhibitory activity for biofilm formation in the organic and aqueous extracts (HAP and MAP) as this was confounded by their strong growth inhibitory activity. On the other hand, the oil macerates (OOO, SOO, UOA, UOB), which lacked the strongly antibacterial hypericin, did demonstrate statistically significant inhibition of biofilm formation in the absence of growth inhibition. Early work with *H. perforatum* attributed antibacterial activity to hyperforin which was present in all the oil macerates (Gurevich et al., [@B19]). While hypericin has stronger antibacterial activity, hyperforin has reported MICs and minimum bactericidal concentrations (MBC) as low as 1 mg mL^−1^ by agar-diffusion assays for some preparations against *S. aureus* (Schempp et al., [@B48]). Based on studies concerning the anti-biofilm effects of hyperforin (Schiavone et al., [@B49]), its MIC, and our documentation of appreciable levels of hyperforin in the traditional oil macerate, could explain---at least in part---the activity observed. Importantly, while other studies have described the anti-biofilm activity of isolated compounds and other *Hypericum* extracts, this is the first report of the biofilm inhibitory activity of the traditional Oleum Hyperici formulation. This data concerning the antibacterial (anti-biofilm and quorum quenching) activity combined with the absence of the harmful photosensitizing agent hypericin, provide compelling evidence of valid efficacious and safe use of this traditional remedy.

Conclusions {#s5}
===========

Different formulations of *H. perforatum* flowering aerial parts are used in traditional medicine, Western herbalism, and in dietary supplements. In this study, we aimed to investigate the safety and antibacterial efficacy of an oil macerate formulation (Oleum Hyperici), which is one of the most common topical therapies for skin and soft tissue infections used in the Balkans as compared to other organic and aqueous extractions, and commercial supplement preparations of the plant. We determined that the traditional preparation of Oleum Hyperici, which involves 40 days of sun exposure in oil, results in a product that lacks the phototoxic naphthodianthrone compound hypericin, responsible for skin sensitization reactions and hypericism, supporting our hypothesis. Our hypothesis concerning the antibacterial activity of Oleum Hyperici was refuted in some assays, and supported in others. Specifically, oil macerates did not inhibit bacterial growth overall, but did significantly inhibit biofilm formation and quorum sensing, which is responsible for the recalcitrant nature of *S. aureus* infections and the regulation of a suite of harmful staphylococcal toxins, respectively. This suggests that the traditional Oleum Hyperici formulation may have more utility in regulation of staphylococcal virulence and pathogenesis rather than classic antibiotic activity.

In conclusion, we have demonstrated that this topical folk-medical therapy for skin and soft tissue infections (including ulcers and wounds) could represent a safe and efficacious therapy for further development. Perhaps the most important consequence of this study is the chemical and biological validation of a traditional medicine, which could continue to play an important role in human medicine in the future. From a union of ethnobotany and biochemical analyses, these findings corroborate the biological mechanism of efficacy of this treatment.
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